Myxoedema coma with complete atrioventricular block: a case report

Ahmet Berk Duman , Hayriye Gökalp , Tarık Erçetin , Selçuk Beniz , Denizhan Karaçimen

Exploration of Endocrine and Metabolic Diseases ›› 2026, Vol. 3 ›› Issue (1) : 101485

PDF (1178KB)
Exploration of Endocrine and Metabolic Diseases ›› 2026, Vol. 3 ›› Issue (1) :101485 DOI: 10.37349/eemd.2026.101485
Case Report
research-article
Myxoedema coma with complete atrioventricular block: a case report
Author information +
History +
PDF (1178KB)

Abstract

Advanced atrioventricular (AV) block can accompany severe hypothyroidism, but thyroid dysfunction does not by itself establish reversibility. A 75-year-old man presented approximately 30 minutes after the onset of dizziness and general deterioration. At the initial documented assessment, temperature was 36.6°C, Glasgow Coma Scale score was 15, oxygen saturation was 98% on room air, and blood pressure was 100/60 mmHg while receiving norepinephrine at 0.05 µg/kg/min. The admission electrocardiogram (ECG) showed complete AV block with an atrial rate of approximately 41–42 beats/min and a markedly slow, wide-complex ventricular escape at approximately 13–14 beats/min. Temporary transvenous pacing increased ventricular rate to approximately 80 beats/min, and coronary angiography showed a dominant right coronary artery, non-obstructive plaques, no culprit lesion, and TIMI 3 flow in all major epicardial vessels. Despite effective rate correction, progressive haemodynamic, respiratory and renal deterioration could no longer be explained by the AV block alone, prompting evaluation for an alternative systemic cause. As respiratory failure progressed, SpO2 fell into the 30% range. At controlled endotracheal intubation, blood pressure was 90/60 mmHg during norepinephrine infusion at 0.2 µg/kg/min, while the temporary pacemaker continued to provide ventricular pacing. Cardiac arrest occurred shortly afterwards, with return of spontaneous circulation after approximately 40 minutes of cardiopulmonary resuscitation. After resuscitation, the previously requested thyroid-function results became available and demonstrated severe primary hypothyroidism (TSH 106 mIU/L, fT3 1.18 pg/mL, fT4 0.38 ng/dL); further history revealed approximately one month of levothyroxine non-adherence. The evolving multisystem syndrome yielded a score of 120 under the 2026 joint-consensus adaptation of the Popoveniuc system, highly suggestive of myxoedema coma. Intravenous hydrocortisone and levothyroxine were initiated. Refractory shock and multiorgan failure persisted, and the patient died on day 3. This case highlights that restoring ventricular rate may not correct a concurrent systemic endocrine crisis and that thyroid dysfunction alone does not prove AV-block reversibility.

Keywords

myxoedema coma / complete atrioventricular block / temporary pacemaker / hypothyroidism / case report

Cite this article

Download citation ▾
Ahmet Berk Duman, Hayriye Gökalp, Tarık Erçetin, Selçuk Beniz, Denizhan Karaçimen. Myxoedema coma with complete atrioventricular block: a case report. Exploration of Endocrine and Metabolic Diseases, 2026, 3 (1) : 101485 DOI:10.37349/eemd.2026.101485

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

Pachucki J, Burmeister LA, Larsen PR. Thyroid Hormone Regulates Hyperpolarization-Activated Cyclic Nucleotide-Gated Channel (HCN2) mRNA in the Rat Heart. Circ Res. 1999; 85: 498-503.

[2]

Ojamaa K, Sabet A, Kenessey A, Shenoy R, Klein I. Regulation of Rat Cardiac Kv1.5 Gene Expression by Thyroid Hormone Is Rapid and Chamber Specific. Endocrinology. 1999; 140: 3170-6.

[3]

Matos LFS, Dos Santos EB, Rocha CSG, Gomes JVS, Marques NRM, Souza DS. Thyroid hormone deficiency-induced cardiac ion channel dysfunction: Molecular mechanisms and arrhythmic implications. Curr Top Membr. 2026; 97: 59-87.

[4]

Alwan H, Hysaj O, Gencer B, Duntas L, Rodondi N. Thyroid dysfunction and cardiovascular disease. Eur Heart J. 2026; 47: 2606-23.

[5]

Kusumoto FM, Schoenfeld MH, Barrett C, Edgerton JR, Ellenbogen KA, Gold MR, et al. 2018 ACC/AHA/HRS Guideline on the Evaluation and Management of Patients With Bradycardia and Cardiac Conduction Delay. J Am Coll Cardiol. 2019; 74: e51-156.

[6]

Glikson M, Nielsen JC, Kronborg MB, Michowitz Y, Auricchio A, Barbash IM, et al. 2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy. Eur Heart J. 2021; 42: 3427-520.

[7]

Schoenmakers N, de Graaff WE, Peters RH. Hypothyroidism as the cause of atrioventricular block in an elderly patient. Neth Heart J. 2008; 16: 57-9.

[8]

Seol SH, Kim DI, Park BM, Kim DK, Song PS, Kim KH, et al. Complete Atrioventricular Block Presenting With Syncope Caused by Severe Hypothyroidism. Cardiol Res. 2012; 3: 239-41.

[9]

Ozcan KS, Osmonov D, Erdinler I, Altay S, Yildirim E, Turkkan C, et al. Atrioventricular block in patients with thyroid dysfunction: Prognosis after treatment with hormone supplementation or antithyroid medication. J Cardiol. 2012; 60: 327-32.

[10]

Yilmaz S, Kilinc M, Adali MK, Buber I, Dursunoglu D. Incidence and Predictors of Complete Atrioventricular Conduction Recovery Among Patients With Heart Block. Future Cardiol. 2021; 17: 677-83.

[11]

Kataoka S, Kobayashi Y, Isogai T, Tanno K, Fukamizu S, Watanabe N, et al. Permanent pacemaker implantation and its predictors in patients admitted for complete atrioventricular block: a report from the Tokyo Cardiovascular Care Unit Network multi-center registry. Heart Vessels. 2020; 35: 1573-82.

[12]

Taylor P, Gibb F, Medici M, Parekh D, Moran C, Duntas L, et al. Management of endocrine emergencies: joint consensus statement for management of myxoedema coma. Eur Thyroid J. 2026; 15: ETJ260044.

[13]

Zhang Y, Chu L, Han H. Myxedema coma: challenges and future directions, a systematic survey and review. Thyroid Res. 2025; 18: 48.

[14]

Popoveniuc G, Chandra T, Sud A, Sharma M, Blackman MR, Burman KD, et al. A Diagnostic Scoring System for Myxedema Coma. Endocr Pract. 2014; 20: 808-17.

[15]

Russotto V, Myatra SN, Laffey JG, Tassistro E, Antolini L, Bauer P, et al.; INTUBE Study Investigators. Intubation Practices and Adverse Peri-intubation Events in Critically Ill Patients From 29 Countries. JAMA. 2021; 325: 1164-72.

[16]

Garcia SI, Smischney NJ, Sandefur BJ, D’Andria Ursoleo J, Kelm DJ, Wieruszewski PM. Peri-intubation Cardiovascular Collapse During Emergency Airway Management. Pulm Ther. 2025; 11: 569-85.

[17]

Kurniawan LB. Non-thyroidal illness (euthyroid sick) syndrome: Laboratory aspects and clinical significance in critically ill patients and other diseases - A narrative review. J Crit Care Med. 2026; 12: 46-55.

PDF (1178KB)

16

Accesses

0

Citation

Detail

Sections
Recommended

/

〈 〉